Olga Kubassova, PhD[email protected]Nuclear MedicineHow medical imaging can accelerate drug developmentIt can take 15 years to get a drug candidate from the lab to approval. Could medical imaging speed up that process? Olga Kubassova, PhD, of Image Analysis Group explains how imaging modalities such as MRI, CT, and PET are helping to track biomarkers in clinical studies, potentially bringing lifesaving therapies to patients more quickly.January 21, 2019Page 1 of 1Top StoriesDigital X-RayBone-RADS improves accuracy for junior, attending physicansACR's Bone-RADS led to improved diagnostic accuracy for junior and attending physicians, but lower accuracy for senior physicians.MRIMRI, CT, ultrasound biomarkers help identify Crohn disease stricturesWomens ImagingLow breast cancer screening prevalence tied to socioeconomic factorsMolecular ImagingPET/CT reveals ‘chemo brain’ regions in leukemia patientsAIStanford AIDE lab proposes radiology AI safety monitoring model